Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Delirium
ADR ID BADD_A01178
ADR Hierarchy
19      Psychiatric disorders
19.13      Deliria (incl confusion)
19.13.02      Deliria
19.13.02.001      Delirium
Description A disorder characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Usually, it is a reversible condition. [CTCAE] A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2) [MeSH]
MedDRA Code 10012218
MeSH ID D003693
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE)
Synonym
Acute brain syndrome | Acute delirium | Brain syndrome acute | Delirious | Delirium | Delirium due to a general medical condition | Delirium nocternal | Delirium nocturnal | Delirium toxic | Delirium, cause unknown | Disorder brain (acute) | Drug-induced delirium | Sensory deprivation delirium | Subacute delirium | Syndrome brain acute | Sundowning | Hypoactive delirium | Hyperactive delirium | Mixed delirium | Subacute Delirium | Delirium, Subacute | Deliriums, Subacute | Subacute Deliriums | Delirium of Mixed Origin | Mixed Origin Delirium | Mixed Origin Deliriums
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02504Lorlatinib0.000504%
BADD_D02507Deutetrabenazine0.000538%
BADD_D02520Baloxavir marboxil0.001694%
BADD_D02540Capmatinib0.000112%
BADD_D02548Darolutamide0.000334%
BADD_D02574Molnupiravir0.000282%
BADD_D02576Opicapone0.000550%
BADD_D02577Oseltamivir acid0.005056%
BADD_D02588Remdesivir0.001044%
The 11th Page    First    Pre   11    Total 11 Pages